Eugene Shenderov | sciencenewsnet.in

Breaking News

Kansas Proving Grounds Partners with SkyScoutAI Innovations Inc. to Deploy AI-Powered Drones for Wildfire Solution at America’s First Carbon Neutral Industrial Park

Perinatal Transmission of HIV Can Lead to Cognitive Deficits

CSUF Grad from Zimbabwe Aims to Improve Access to Mental Health Services

Alzheimer’s Consortium set to bring experts and families together at ASU

Critical Minerals Recovery from Electronic Waste

The Pediatric Emergency Department at Joseph M. Sanzari Children’s Hospital Becomes the First Autism Certified Center in the State

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Landmark Conference Celebrating Betty Ford’s Legacy as First Lady, With Notable Expert Panels

New study points to racial and social barriers that block treatment for multiple myeloma

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

24 Apr, 2024

Novel Immunotherapy Agent Safe, Shows Promise Against High-Risk Prostate Cancers

April 6, 2023 sarah JonasResearch Results

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.